Kirjahaku

"Dr Brooks is able to document the structural basis of power, patronage and prejudice.... should be read and valued by a wide audience".Ann Oakley* How and why have women academics experienced patterns of exclusion, segregation and discrimination in higher education?* To what extent are academic relationships characterized by endemic sexism in defence of male privilege?* What parallels are there in patterns of discrimination and disadvantage for academic women in different cultural contexts?Academic Women explores these questions and investigates the relationships between gender, power and the academy through an analysis of the position of academic women in higher education in the UK and New Zealand. It considers the gap between the models of equality and academic fairness which are said to characterize academic life and the sexist reality of the academy. Ann Brooks combines new and original data drawn from statistical evidence and from the results of questionnaires and interviews with British and New Zealand women academics; and this evidence is located within a wider framework of historical evidence on the position of academic women in both countries.

Presents an Cyber-Assurance approach to the Internet of Things (IoT)This book discusses the cyber-assurance needs of the IoT environment, highlighting key information assurance (IA) IoT issues and identifying the associated security implications. Through contributions from cyber-assurance, IA, information security and IoT industry practitioners and experts, the text covers fundamental and advanced concepts necessary to grasp current IA issues, challenges, and solutions for the IoT. The future trends in IoT infrastructures, architectures and applications are also examined. Other topics discussed include the IA protection of IoT systems and information being stored, processed or transmitted from unauthorized access or modification of machine-2-machine (M2M) devices, radio-frequency identification (RFID) networks, wireless sensor networks, smart grids, and supervisory control and data acquisition (SCADA) systems. The book also discusses IA measures necessary to detect, protect, and defend IoT information and networks/systems to ensure their availability, integrity, authentication, confidentially, and non-repudiation. Discusses current research and emerging trends in IA theory, applications, architecture and information security in the IoT based on theoretical aspects and studies of practical applicationsAids readers in understanding how to design and build cyber-assurance into the IoTExposes engineers and designers to new strategies and emerging standards, and promotes active development of cyber-assuranceCovers challenging issues as well as potential solutions, encouraging discussion and debate amongst those in the fieldCyber-Assurance for the Internet of Things is written for researchers and professionals working in the field of wireless technologies, information security architecture, and security system design. This book will also serve as a reference for professors and students involved in IA and IoT networking.Tyson T. Brooks is an Adjunct Professor in the School of Information Studies at Syracuse University; he also works with the Center for Information and Systems Assurance and Trust (CISAT) at Syracuse University, and is an information security technologist and science-practitioner. Dr. Brooks is the founder/Editor-in-Chief of the International Journal of Internet of Things and Cyber-Assurance, an associate editor for the Journal of Enterprise Architecture, the International Journal of Cloud Computing and Services Science, and the International Journal of Information and Network Security.

Reproduction of the original: Zophiel by Mrs. Brooks

Reproduction of the original: Zophiel by Mrs. Brooks

Non-steroidal anti-inflammatory drugs (NSAIDs) are one of the most commonly prescribed groups of drugs in the community. This reflects the high frequency of rheumatic complaints but may in part be due to the relative non efficacy of these drugs. Since the introduction of ibuprofen, the first new NSAID to compete with aspirin, phenylbutazone and indomethacin, there has been a proliferation of new NSAIDs of differing chemical classes but an apparent similar spectrum of action. Despite the fact that these drugs are thought to work by an apparent common mechanism of action (suppression of prostaglandin synthetase activity) continued development of these drugs occurs. There exists at present a conflict between the pharmaceutical industry with its attempts to introduce new NSAIDs and drug regulatory authorities who are generally not convinced of the need for additional drugs of_ this class. The practising clinician regards a variety of NSAIDs as necessary to enable pain relief to be optimised.with minimal adverse effects. With respect to the dilemma of how many NSAIDs are really necessary surprisingly little convincing data is available to assist in resolving this issue. It was therefore decided to hold a satellite meeting to the XVIth International League Against Rheumatism Conference in May 1985.